AtriCure (ATRC) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $31.79 +6.93%
Revenue Growth %: +11.6%
Financial Fact:
Total operating expenses: 33.76M
Today's EPS Names:
CRMT, More
Revenue Growth %: +11.6%
Financial Fact:
Total operating expenses: 33.76M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $49.9 million versus the consensus estimate of $48.13 million.
GUIDANCE:
AtriCure sees FY2018 EPS of ($0.69)-($0.74), versus the consensus of ($0.69). AtriCure sees FY2018 revenue of $198-201 million, versus the consensus of $197.91 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
- Lucid reports Q2 output, names new CFO and five other leaders
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
